Allogeneic transplantation for lymphoma: risk-benefit balance is in the eye of the beholder

Biol Blood Marrow Transplant. 2014 Jul;20(7):905-6. doi: 10.1016/j.bbmt.2014.05.007. Epub 2014 May 14.

Author

Mitchell R Smith¹

Affiliation

¹ Lymphoid Malignancies Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: smithm14@ccf.org.

PMID: 24831132
DOI: 10.1016/j.bbmt.2014.05.007

No abstract available

Publication types

Comment

MeSH terms

Female
Hematopoietic Stem Cell Transplantation / methods*
Humans
Lymphoma, Non-Hodgkin / therapy*
Male
Transplantation Conditioning / methods*